Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy : EORTC 22911.

Van der Kwast, Theodorus H;Bolla, Michel;Van Poppel, Hein;Van Cangh, Paul;Collette, Laurence;et.al.
(2007) Journal of clinical oncology : official journal of the American Society of Clinical Oncology — Vol. 25, n° 27, p. 4178-4186 (2007)

Files

VanderKwast-2007-Identificationofpatients.pdf
  • Restricted Access
  • Adobe PDF
  • 228.29 KB
Request a copy

Details

Authors
  • Van der Kwast, Theodorus H
    Author
  • Bolla, Michel
    Author
  • Van Poppel, Hein
    Author
  • Van Cangh, PaulUCLouvain
    Author
  • Collette, Laurence
    Author
Show more
Abstract
The randomized controlled European Organisation for Research and Treatment of Cancer (EORTC) trial 22911 studied the effect of radiotherapy after prostatectomy in patients with adverse risk factors. Review pathology data of specimens from participants in this trial were analyzed to identify which factors predict increased benefit from adjuvant radiotherapy.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Van der Kwast, T. H., Bolla, M., Van Poppel, H., Van Cangh, P., Vekemans, K., Da Pozzo, L., Bosset, J.-F., Kurth, K. H., Schröder, F. H., & Collette, L. (2007). Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy : EORTC 22911. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25(27), 4178-4186. https://doi.org/10.1200/JCO.2006.10.4067 (Original work published 2007)